Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Besifloxacin in Bacterial Keratitis
NCT02497365Completed
- Sponsor
- McGill University Health Centre
- Start
- Sep 2015
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
Randomised, open-label trial of Besifloxacin ophthalmic suspension vehicle in bacterial keratitis (2 arms), sponsored by McGill University Health Centre. Primary endpoint: Time to microbial sterilization of the infected cornea. Started Sep 2015; status: completed.
02
Drugs
Besifloxacin ophthalmic suspension vehicle
03
Conditions
bacterial keratitis
Beyond the preview
Go deeper on NCT02497365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02497365.